|
| 6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine Basic information |
Product Name: | 6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine | Synonyms: | 6-(Benzyloxy)-9-(1S,3R,3S)-4-(benzyloxy)-3-(benzyoxymethyl)-2-methylenecyclopentyl)-N-N-(4-methyoxyphenyl)diaphenylmethyl)-9H-purin-2-amine;6-(benzyloxy)-9-(1S,3R,3S)-4-(benzyloxy)_3-(benzyoxymethyl)-2-methylenecyclopentyl)-N-N
-(4-methyoxyphenyl)diaphenylmethyl)-9H-purin-2-amino;6-(Benzyloxy)-9-((1S,3R,3S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine;[1S-(1α,3α,4β)]-N-[(4-Methoxyphenyl)diphenyl-Methyl]-6-(phenylMethoxy)-9-[2-Methylene-4-(phenylMethoxy)-3-[(phenylMethoxy)Methyl]-cyclopentyl]-9H-purin-2-aMine;Entecavir InterMediate VII;N-[(4-Methoxyphenyl)diphenylMethyl]-9-[(1S,3R,4S)-2-Methylene-4-(benzyloxy)-3-[(benzyloxy)Methyl]cyclopentyl]-6-(benzyloxy)-9H-Purin-2-aMine;Entecavir-7;Entecavir interMediate 7 | CAS: | 142217-80-9 | MF: | C53H49N5O4 | MW: | 819.99 | EINECS: | 1806241-263-5 | Product Categories: | | Mol File: | 142217-80-9.mol | |
| 6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine Chemical Properties |
| 6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine Usage And Synthesis |
Chemical Properties | White powder | Definition | 6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine is also known as Entecavir Impurity 3. Entecavir belongs to the family of medicines called antivirals. Entecavir is used to treat liver infections caused by hepatitis B virus. |
| 6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine Preparation Products And Raw materials |
Raw materials | 4-Methoxytriphenylmethyl chloride-->Benzene, [(2,4-cyclopentadien-1-ylmethoxy)methyl]--->(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(benzyloxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanone-->(1S,2R,3S,5R)-2-(Benzyloxymethyl)-6-oxabicyclo[3.1.0]hexan-3-ol-->SODIUM CYCLOPENTADIENIDE-->(1S,2R,3S,5R)-3-(Phenymethyloxy)-2-(phenylmethoxy)methyl-6-oxabicyclo[3.1.0]hexane-->(1S, 2R)-2-(Benzyloxymethyl)-1-hydroxy-3-cyclopentene-->(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol-->(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol-->Benzyl chloromethyl ether-->Dibromomethane | Preparation Products | 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one |
|